EcoDrugPlus

Substance-P Receptor-Like

Ensembl ID : ENSPREG00000009343
Gene Symbol: LOC103462827
3 Cross references
196 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPREG00000015318
Gene Symbol: TACR1
3 Cross references
194 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPREG00000018408
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSPREG00000021289
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor-Like

Ensembl ID : ENSPREG00000007915
Gene Symbol: LOC103463442
3 Cross references
191 Possible Orthologues:

Thromboxane A2 Receptor-Like

Ensembl ID : ENSPREG00000007892
Gene Symbol: LOC103463443
3 Cross references
191 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSPREG00000007696
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSPREG00000015135
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSPREG00000014380
Gene Symbol: TRHRB
1 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSPREG00000011696
Gene Symbol: LOC103479234
2 Cross references
172 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSPREG00000007849
Gene Symbol: TLR2
2 Cross references
206 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSPREG00000001927
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).